Cause of death, by non-communicable diseases, ages 0-4, female in Cyprus
Cyprus: Cause of death, by non-communicable diseases, ages 0-4, female was 39.0% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 0-4, female in Cyprus, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
Cyprus recorded 39.0% for cause of death, by non-communicable diseases, ages 0-4, female in 2021.
That represents a change of up 0.1% on the previous year and up 30.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Cyprus peaked at 43.4% in 2000 and was at its lowest, 29.9%, in 2010.
Cyprus ranks 54th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4, female in Cyprus, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 43.4% | — |
| 2010 | 29.9% | -31.2% |
| 2015 | 34.2% | +14.5% |
| 2019 | 38.6% | +12.7% |
| 2020 | 39.0% | +1.0% |
| 2021 | 39.0% | +0.1% |
Cyprus compared with similar countries
- Cyprus's 39.0% is below the median for high income countries, which is 42.8%, 91% of the median. (58 countries reporting)
- Cyprus's 39.0% is below the median for Europe & Central Asia, which is 39.9%, 98% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 43.4% | 43.4% | 43.4% | 1 |
| 2010s | 34.2% | 29.9% | 38.6% | 3 |
| 2020s | 39.0% | 39.0% | 39.0% | 2 |
Countries ranked near Cyprus
More health data for Cyprus
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.51 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,325 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.0526 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0263 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.0182 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Cyprus?
- Cause of death, by non-communicable diseases, ages 0-4, female in Cyprus was 39.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Cyprus?
- The highest recorded value was 43.4% in 2000.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Cyprus?
- The lowest recorded value was 29.9% in 2010.
- How does Cyprus rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Cyprus ranks 54th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Cyprus?
- Over the last ten years it is up 30.5%. The long-run trend across the full record is falling.
- Where does this Cyprus data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.